Evidence for modulation of human epidermal differentiation and remodelling by CD40

被引:7
作者
Concha, M
Vidal, MA
Moreno, I
Salem, C
Figueroa, CD
Schmitt, D
Péguet-Navarro, J
机构
[1] Univ Austral Chile, Fac Med, Inst Histol & Patol, Valdivia, Chile
[2] Univ Austral Chile, Fac Med, Inst Especialidades, Valdivia, Chile
[3] Univ Austral Chile, Fac Med, Inst Cirugia, Valdivia, Chile
[4] Hop Edouard Herriot, INSERM, U346, Lyon, France
关键词
CD40; differentiation; filaggrin; interferon-gamma; keratinocyte; Ki-67;
D O I
10.1046/j.1365-2133.2003.05300.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background It is widely accepted that CD40 plays a critical role in the regulation of immune response. However, the significance of CD40 expression on normal human keratinocytes is only partially known. Objectives To perform a morphological re-examination of the role of CD40 on the differentiation of human keratinocytes and remodelling of the epidermis. Methods Keratinocytes were grown on fibroblasts transfected with the CD40 ligand (CD40L) to investigate the formation of epidermal sheets in culture under the influence of the CD40L. Control experiments were carried out using the same cells but transfected with CD32. Further, three specific anti-CD40 monoclonal antibodies were used as soluble agonists to analyse the effect of CD40 ligation on keratinocyte differentiation. Results Epidermal sheets developing from keratinocytes cocultured with fibroblasts transfected with CD40L but not with CD32 showed an up to 50% reduction in thickness compared with control sheets. This change depended mostly on cellular flattening and a decrease in the number of cell layers. and was coincident with a transient decrease in cell surface CD40 immunoreactivity. On the other hand, normal epidermis, and freshly isolated and cultured keratinocytes revealed a predominant CD40+/Ki-67- phenotype that was demonstrated by double immunocytochemistry. Consistent with these observations, keratinocytes primed with interferon-gamma responded to the three soluble agonists, but not to control IgG1, producing immunoreactive (pro)filaggrin and displaying morphological changes in shape and size equivalent to those seen in differentiated cells. Conclusions As a whole, our findings provide evidence that CD40+ keratinocytes represent a poorly differentiated population, not actively engaged in the cell cycle, which under specific stimulation is committed towards terminal differentiation.
引用
收藏
页码:1105 / 1114
页数:10
相关论文
共 36 条
[11]   CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype [J].
Galibert, L ;
Burdin, N ;
deSaintVis, B ;
Garrone, P ;
VanKooten, C ;
Banchereau, J ;
Rousset, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :77-85
[12]  
GALY AHM, 1992, J IMMUNOL, V149, P775
[13]   Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism [J].
Gaspari, AA ;
Sempowski, GD ;
Chess, P ;
Gish, J ;
Phipps, RP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) :1371-1377
[14]  
GERDES J, 1984, J IMMUNOL, V133, P1710
[15]  
Grammer AC, 1998, J IMMUNOL, V161, P1183
[16]   CD40 ligation alters the cell cycle of differentiating keratinocytes [J].
Grousson, J ;
Ffrench, M ;
Concha, M ;
Schmitt, D ;
Péguet-Navarro, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 114 (03) :581-586
[17]   Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region [J].
Ishida, T ;
Mizushima, S ;
Azuma, S ;
Kobayashi, N ;
Tojo, T ;
Suzuki, K ;
Aizawa, S ;
Watanabe, T ;
Mosialos, G ;
Kieff, E ;
Yamamoto, T ;
Inoue, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28745-28748
[18]   TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling [J].
Ishida, T ;
Tojo, T ;
Aoki, T ;
Kobayashi, N ;
Ohishi, T ;
Watanabe, T ;
Yamamoto, T ;
Inoue, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) :9437-9442
[19]  
Li YY, 1996, J IMMUNOL, V157, P1440
[20]  
MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117